CE-2013.3.31-10Q


 
 
 
 
 
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
_______________________________________________________
Form 10-Q
þ
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2013
 
Or
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
(Commission File Number) 001-32410
CELANESE CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
98-0420726
(I.R.S. Employer
Identification No.)
 
 
222 W. Las Colinas Blvd., Suite 900N
Irving, TX
(Address of Principal Executive Offices)
75039-5421
(Zip Code)
(972) 443-4000
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ  No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ
Accelerated filer o
Non-accelerated filer o (Do not check if a smaller reporting company)
Smaller reporting company o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o  No þ
The number of outstanding shares of the registrant’s Series A common stock, $0.0001 par value, as of April 15, 2013 was 159,651,273.
 
 
 
 
 




CELANESE CORPORATION AND SUBSIDIARIES

Form 10-Q
For the Quarterly Period Ended March 31, 2013

TABLE OF CONTENTS
 
 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 


2




Item 1. Financial Statements 
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
 
Three Months Ended
 
March 31,
 
2013
 
2012
 
 
 
As Adjusted (Note 1)
 
(In $ millions, except share
and per share data)
Net sales
1,605

 
1,633

Cost of sales
(1,272
)
 
(1,359
)
Gross profit
333

 
274

Selling, general and administrative expenses
(106
)
 
(126
)
Amortization of intangible assets
(11
)
 
(13
)
Research and development expenses
(26
)
 
(25
)
Other (charges) gains, net
(4
)
 

Foreign exchange gain (loss), net
(1
)
 
1

Gain (loss) on disposition of businesses and assets, net
(1
)
 

Operating profit (loss)
184

 
111

Equity in net earnings (loss) of affiliates
54

 
51

Interest expense
(43
)
 
(45
)
Refinancing expense

 

Interest income

 
1

Dividend income - cost investments
24

 

Other income (expense), net
(1
)
 
2

Earnings (loss) from continuing operations before tax
218

 
120

Income tax (provision) benefit
(77
)
 
73

Earnings (loss) from continuing operations
141

 
193

Earnings (loss) from operation of discontinued operations
2

 

Gain (loss) on disposition of discontinued operations

 

Income tax (provision) benefit from discontinued operations
(1
)
 

Earnings (loss) from discontinued operations
1

 

Net earnings (loss)
142

 
193

Net (earnings) loss attributable to noncontrolling interests

 

Net earnings (loss) attributable to Celanese Corporation
142

 
193

Amounts attributable to Celanese Corporation
 

 
 

Earnings (loss) from continuing operations
141

 
193

Earnings (loss) from discontinued operations
1

 

Net earnings (loss)
142

 
193

Earnings (loss) per common share - basic
 

 
 

Continuing operations
0.88

 
1.23

Discontinued operations
0.01

 

Net earnings (loss) - basic
0.89

 
1.23

Earnings (loss) per common share - diluted
 

 
 

Continuing operations
0.88

 
1.21

Discontinued operations
0.01

 

Net earnings (loss) - diluted
0.89

 
1.21

Weighted average shares - basic
159,682,386

 
156,576,896

Weighted average shares - diluted
160,201,636

 
159,115,232


See the accompanying notes to the unaudited interim consolidated financial statements.

3



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (LOSS)

 
Three Months Ended
 
March 31,
 
2013
 
2012
 
 
 
As Adjusted (Note 1)
 
(In $ millions)
Net earnings (loss)
142

 
193

Other comprehensive income (loss), net of tax
 

 
 

Unrealized gain (loss) on marketable securities

 

Foreign currency translation
(31
)
 
26

Gain (loss) on interest rate swaps
1

 
1

Pension and postretirement benefits

 
(4
)
Total other comprehensive income (loss), net of tax
(30
)
 
23

Total comprehensive income (loss), net of tax
112

 
216

Comprehensive (income) loss attributable to noncontrolling interests

 

Comprehensive income (loss) attributable to Celanese Corporation
112

 
216


See the accompanying notes to the unaudited interim consolidated financial statements.


4



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETS
 
As of
March 31,
2013
 
As of
December 31,
2012
 
 
 
As Adjusted (Note 1)
 
(In $ millions, except share data)
ASSETS
 
 
 
Current Assets
 

 
 

Cash and cash equivalents
978

 
959

Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2013: $10; 2012: $9)
916

 
827

Non-trade receivables, net
197

 
209

Inventories
758

 
711

Deferred income taxes
50

 
49

Marketable securities, at fair value
49

 
53

Other assets
38

 
31

Total current assets
2,986

 
2,839

Investments in affiliates
796

 
800

Property, plant and equipment (net of accumulated depreciation - 2013: $1,536; 2012: $1,506)
3,286

 
3,350

Deferred income taxes
603

 
606

Other assets
480

 
463

Goodwill
762

 
777

Intangible assets, net
155

 
165

Total assets
9,068

 
9,000

LIABILITIES AND EQUITY
 
 
 
Current Liabilities
 

 
 

Short-term borrowings and current installments of long-term debt - third party and affiliates
112

 
168

Trade payables - third party and affiliates
659

 
649

Other liabilities
459

 
475

Deferred income taxes
25

 
25

Income taxes payable
96

 
38

Total current liabilities
1,351

 
1,355

Long-term debt
2,959

 
2,930

Deferred income taxes
44

 
50

Uncertain tax positions
180

 
181

Benefit obligations
1,576

 
1,602

Other liabilities
1,123

 
1,152

Commitments and Contingencies


 


Stockholders’ Equity
 

 
 

Preferred stock, $0.01 par value, 100,000,000 shares authorized (2013 and 2012: 0 issued and outstanding)

 

Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2013: 183,666,930 issued and 159,680,094 outstanding; 2012: 183,629,237 issued and 159,642,401 outstanding)

 

Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2013 and 2012: 0 issued and outstanding)

 

Treasury stock, at cost (2013: 23,986,836 shares; 2012: 23,986,836 shares)
(905
)
 
(905
)
Additional paid-in capital
736

 
731

Retained earnings
2,123

 
1,993

Accumulated other comprehensive income (loss), net
(119
)
 
(89
)
Total Celanese Corporation stockholders’ equity
1,835

 
1,730

Noncontrolling interests

 

Total equity
1,835

 
1,730

Total liabilities and equity
9,068

 
9,000


See the accompanying notes to the unaudited interim consolidated financial statements.

5



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENT OF EQUITY
 
Three Months Ended
 
March 31, 2013
 
Shares
 
Amount
 
 
 
As Adjusted (Note 1)
 
(In $ millions, except share data)
Series A Common Stock
 

 
 

Balance as of the beginning of the period
159,642,401

 

Stock option exercises
36,900

 

Purchases of treasury stock

 

Stock awards
793

 

Balance as of the end of the period
159,680,094

 

Treasury Stock
 

 
 

Balance as of the beginning of the period
23,986,836

 
(905
)
Purchases of treasury stock, including related fees

 

Balance as of the end of the period
23,986,836

 
(905
)
Additional Paid-In Capital
 

 
 

Balance as of the beginning of the period
 

 
731

Stock-based compensation, net of tax
 

 
4

Stock option exercises, net of tax
 

 
1

Balance as of the end of the period
 

 
736

Retained Earnings
 

 
 

Balance as of the beginning of the period
 

 
1,993

Net earnings (loss) attributable to Celanese Corporation
 

 
142

Series A common stock dividends
 

 
(12
)
Balance as of the end of the period
 

 
2,123

Accumulated Other Comprehensive Income (Loss), Net
 

 
 

Balance as of the beginning of the period
 

 
(89
)
Other comprehensive income (loss), net of tax
 

 
(30
)
Balance as of the end of the period
 

 
(119
)
Total Celanese Corporation stockholders’ equity
 

 
1,835

Noncontrolling Interests
 

 
 

Balance as of the beginning of the period
 

 

Net earnings (loss) attributable to noncontrolling interests
 

 

Balance as of the end of the period
 

 

Total equity
 

 
1,835


See the accompanying notes to the unaudited interim consolidated financial statements.



6



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Three Months Ended
 
March 31,
 
2013
 
2012
 
 
 
As Adjusted (Note 1)
 
(In $ millions)
Operating Activities
 

 
 

Net earnings (loss)
142

 
193

Adjustments to reconcile net earnings (loss) to net cash provided by operating activities
 

 
 

Other charges (gains), net of amounts used
(4
)
 
(4
)
Depreciation, amortization and accretion
80

 
77

Pension and postretirement benefit expense
(5
)
 
3

Pension and postretirement contributions
(19
)
 
(66
)
Deferred income taxes, net
(8
)
 
(91
)
(Gain) loss on disposition of businesses and assets, net
1

 

Refinancing expense

 

Other, net
2

 
72

Operating cash provided by (used in) discontinued operations
1

 

Changes in operating assets and liabilities
 

 
 

Trade receivables - third party and affiliates, net
(100
)
 
(47
)
Inventories
(55
)
 
(32
)
Other assets
(7
)
 
19

Trade payables - third party and affiliates
36

 
123

Other liabilities
83

 
(32
)
Net cash provided by (used in) operating activities
147

 
215

Investing Activities
 

 
 

Capital expenditures on property, plant and equipment
(74
)
 
(106
)
Acquisitions, net of cash acquired

 
(23
)
Proceeds from sale of businesses and assets, net

 

Capital expenditures related to Kelsterbach plant relocation
(3
)
 
(21
)
Other, net
(10
)
 
(5
)
Net cash provided by (used in) investing activities
(87
)
 
(155
)
Financing Activities
 

 
 

Short-term borrowings (repayments), net
(19
)
 
10

Proceeds from short-term debt
24

 
24

Repayments of short-term debt
(24
)
 
(24
)
Proceeds from long-term debt
50

 

Repayments of long-term debt
(55
)
 
(8
)
Purchases of treasury stock, including related fees

 
(20
)
Stock option exercises
1

 
7

Series A common stock dividends
(12
)
 
(10
)
Other, net

 

Net cash provided by (used in) financing activities
(35
)
 
(21
)
Exchange rate effects on cash and cash equivalents
(6
)
 
6

Net increase (decrease) in cash and cash equivalents
19

 
45

Cash and cash equivalents as of beginning of period
959

 
682

Cash and cash equivalents as of end of period
978

 
727


See the accompanying notes to the unaudited interim consolidated financial statements.


7



CELANESE CORPORATION AND SUBSIDIARIES
NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
1. Description of the Company and Basis of Presentation
Description of the Company
Celanese Corporation and its subsidiaries (collectively, the "Company") is a global technology and specialty materials company. The Company’s business involves processing chemical raw materials, such as methanol, carbon monoxide and ethylene, and natural products, including wood pulp, into value-added chemicals, thermoplastic polymers and other chemical-based products.
Definitions
In this Quarterly Report, the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese US" refers to the Company’s subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
Basis of Presentation
The unaudited interim consolidated financial statements for the three months ended March 31, 2013 and 2012 contained in this Quarterly Report on Form 10-Q ("Quarterly Report") were prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP") for all periods presented. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.
In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with US GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements as of and for the year ended December 31, 2012, filed on February 8, 2013 with the SEC as part of the Company’s Annual Report on Form 10-K.
Operating results for the three months ended March 31, 2013 are not necessarily indicative of the results to be expected for the entire year.
In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company’s business in this Quarterly Report.
For those consolidated subsidiaries in which the Company's ownership is less than 100%, the outside stockholders' interests are shown as noncontrolling interests.
The Company has reclassified certain prior period amounts to conform to the current period’s presentation.
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of revenues, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.

8



Change in accounting policy regarding pension and other postretirement benefits
Effective January 1, 2013, the Company elected to change its accounting policy for recognizing actuarial gains and losses and changes in the fair value of plan assets for its defined benefit pension plans and other postretirement benefit plans. Previously, the Company recognized the actuarial gains and losses as a component of Accumulated other comprehensive income (loss), net within the consolidated balance sheets on an annual basis and amortized the gains and losses into operating results over the average remaining service period to retirement date for active plan participants or, for retired participants, the average remaining life expectancy. For defined benefit pension plans, the unrecognized gains and losses were amortized when the net gains and losses exceeded 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. For other postretirement benefits, amortization occurred when the net gains and losses exceeded 10% of the accumulated postretirement benefit obligation at the beginning of the year.
Previously, differences between the actual rate of return on plan assets and the long-term expected rate of return on plan assets were not generally recognized in net periodic benefit cost in the year that the difference occurred. These differences were deferred and amortized into net periodic benefit cost over the average remaining future service period of employees. The asset gains and losses subject to amortization and the long-term expected return on plan assets were previously calculated using a five-year smoothing of asset gains and losses referred to as the market-related value to stabilize variability in the plan asset values.
The Company now applies the long-term expected rate of return to the fair value of plan assets and immediately recognizes the change in fair value of plan assets and net actuarial gains and losses annually in the fourth quarter of each fiscal year and whenever a plan is required to be remeasured. Events requiring a plan remeasurement will be recognized in the quarter in which such remeasurement event occurs. The remaining components of the Company's net periodic benefit cost are recorded on a quarterly basis. While the Company's historical policy of recognizing the change in fair value of plan assets and net actuarial gains and losses is considered acceptable under US GAAP, the Company believes the new policy is preferable as it eliminates the delay in recognizing gains and losses within operating results. This change improves transparency within the Company's operating results by immediately recognizing the effects of economic and interest rate trends on plan investments and assumptions in the year these gains and losses are actually incurred. The policy changes have no impact on future pension and postretirement benefit plan funding or pension and postretirement benefits paid to participants. Financial information for all periods presented has been retrospectively adjusted.
In connection with the changes in accounting policy for pension and other postretirement benefits and in an attempt to properly match the actual operational expenses each business segment is incurring, the Company changed its allocation of net periodic benefit cost. Previously, the Company allocated all components of net periodic benefit cost to each business segment on a ratable basis. The Company now allocates only the service cost and amortization of prior service cost components of its pension and postretirement plans to its business segments. All other components of net periodic benefit cost are recorded to Other Activities. The components of net periodic benefit cost that are no longer allocated to each business segment include interest cost, expected return on assets and net actuarial gains and losses as these components are considered financing activities managed at the corporate level. The Company believes the revised expense allocation more appropriately matches the cost incurred for active employees to the respective business segment. Business segment information for prior periods has been retrospectively adjusted (Note 18).

9



The retrospective effect of the change in accounting policy for pension and other postretirement benefits to the consolidated statement of operations is as follows:
 
Three Months Ended March 31, 2012
 
As Previously
Reported
 
Effect of
Change
 
As Adjusted
 
(In $ millions, except per share data)
Cost of sales
(1,363
)
 
4

 
(1,359
)
Gross profit
270

 
4

 
274

Selling, general and administrative expenses
(134
)
 
8

 
(126
)
Research and development expenses
(26
)
 
1

 
(25
)
Operating profit (loss)
98

 
13

 
111

Earnings (loss) from continuing operations before tax
107

 
13

 
120

Income tax (provision) benefit
76

 
(3
)
 
73

Earnings (loss) from continuing operations
183

 
10

 
193

Net earnings (loss)
183

 
10

 
193

Net earnings (loss) attributable to Celanese Corporation
183

 
10

 
193

Earnings (loss) per common share - basic
 
 
 
 
 
Continuing operations
1.17

 
0.06

 
1.23

Discontinued operations

 

 

Net earnings (loss) - basic
1.17

 
0.06

 
1.23

Earnings (loss) per common share - diluted
 
 
 
 
 
Continuing operations
1.15

 
0.06

 
1.21

Discontinued operations

 

 

Net earnings (loss) - diluted
1.15

 
0.06

 
1.21

The retrospective effect of the change in accounting policy for pension and other postretirement benefits to the consolidated statement of comprehensive income (loss) is as follows:
 
Three Months Ended March 31, 2012
 
As Previously
Reported
 
Effect of
Change
 
As Adjusted
 
(In $ millions)
Net earnings (loss)
183

 
10

 
193

Pension and postretirement benefits
6

 
(10
)
 
(4
)
Total other comprehensive income (loss), net of tax
33

 
(10
)
 
23

Total comprehensive income (loss), net of tax
216

 

 
216

Comprehensive (income) loss attributable to Celanese Corporation
216

 

 
216

The retrospective effect of the change in accounting policy for pension and other postretirement benefits to the consolidated balance sheet is as follows:
 
As of December 31, 2012
 
As Previously
Reported
 
Effect of
Change
 
As Adjusted
 
(In $ millions)
Retained earnings
2,986

 
(993
)
 
1,993

Accumulated other comprehensive income (loss), net
(1,082
)
 
993

 
(89
)
The cumulative effect of the change in accounting policy for pension and other postretirement benefits on Retained earnings as of December 31, 2011 was a decrease of $760 million, with an equivalent increase to Accumulated other comprehensive income.

10



The retrospective effect of the change in accounting policy for pension and other postretirement benefits to the consolidated statement of cash flows is as follows:
 
Three Months Ended March 31, 2012
 
As Previously
Reported
 
Effect of
Change
 
As Adjusted
 
(In $ millions)
Net earnings (loss)
183

 
10

 
193

Pension and postretirement benefit expense

 
3

 
3

Pension and postretirement contributions

 
(66
)
 
(66
)
Deferred income taxes, net
(94
)
 
3

 
(91
)
Other liabilities
(82
)
 
50

 
(32
)
The retrospective effect of the change in accounting policy for pension and other postretirement benefits to the business segment financial information (Note 18) is as follows:
 
Three Months Ended March 31, 2012
 
As Previously
Reported
 
Effect of
Change
 
As Adjusted
 
(In $ millions)
Operating Profit (Loss)
 
 
 
 
 
Advanced Engineered Materials
21

 
3

 
24

Consumer Specialties
39

 
1

 
40

Industrial Specialties
19

 
1

 
20

Acetyl Intermediates
60

 
2

 
62

Other Activities
(41
)
 
6

 
(35
)
Total
98

 
13

 
111

2. Recent Accounting Pronouncements
In March 2013, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2013-05, Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, an amendment to FASB Accounting Standards Codification ("ASC") Topic 830, Foreign Currency Matters ("FASB ASC Topic 830"). The update clarifies that complete or substantially complete liquidation of a foreign entity is required to release the cumulative translation adjustment ("CTA") for transactions occurring within a foreign entity. However, transactions impacting investments in a foreign entity may result in a full or partial release of CTA even though complete or substantially complete liquidation of the foreign entity has not occurred. Furthermore, for transactions involving step acquisitions, the CTA associated with the previous equity-method investment will be fully released when control is obtained and consolidation occurs. This ASU is effective for fiscal years beginning after December 15, 2013. The Company will apply the guidance prospectively to derecognition events occurring after the effective date.
In February 2013, the FASB issued ASU 2013-04, Obligations Resulting From Joint and Several Liability Arrangements for Which the Total Amount of the Obligation is Fixed at the Reporting Date, an amendment to FASB ASC Topic 405, Liabilities ("FASB ASC Topic 405"). The update requires an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation is fixed as of the reporting date as the sum of the obligation the entity agreed to pay among its co-obligors and any additional amount the entity expects to pay on behalf of its co-obligors. This ASU is effective for annual and interim periods beginning after December 15, 2013 and is required to be applied retrospectively to all prior periods presented for those obligations that existed upon adoption of the ASU. The Company is still assessing the potential impact of adopting this guidance.

11



3. Acquisitions, Dispositions, Ventures and Plant Closures
Acquisitions
In January 2012, the Company completed the acquisition of certain assets from Ashland Inc., including two product lines, Vinac® and Flexbond®, to support the strategic growth of the Company's Emulsions business (Note 6). The acquired operations are included in the Industrial Specialties segment. Pro forma financial information since the acquisition date has not been provided as the acquisition did not have a material impact on the Company’s financial information.
The Company allocated the purchase price of the acquisitions to identifiable intangible assets acquired based on their estimated fair values. The excess of purchase price over the aggregate fair values was recorded as goodwill. Intangible assets were valued using the relief from royalty and discounted cash flow methodologies which are considered Level 3 measurements under FASB ASC Topic 820, Fair Value Measurement ("FASB ASC Topic 820"). The relief from royalty method estimates the Company’s theoretical royalty savings from ownership of the intangible asset. Key assumptions used in this model include discount rates, royalty rates, growth rates, sales projections and terminal value rates, all of which require significant management judgment and, therefore, are susceptible to change. The key assumptions used in the discounted cash flow valuation model include discount rates, growth rates, cash flow projections and terminal value rates. Discount rates, growth rates and cash flow projections are the most sensitive and susceptible to change as they require significant management judgment. The Company, with the assistance of third-party valuation consultants, calculated the fair value of the intangible assets acquired to allocate the purchase price at the acquisition date.
4. Marketable Securities, at Fair Value
The Company’s captive insurance companies and nonqualified trusts hold available-for-sale securities for capitalization and funding requirements, respectively.
The amortized cost, gross unrealized gain, gross unrealized loss and fair values for available-for-sale securities by major security type are as follows:
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Mutual Funds
 
 
 
Amortized cost
49

 
53

Gross unrealized gain

 

Gross unrealized loss

 

Fair value
49

 
53

See Note 16, Fair Value Measurements, for additional information regarding the fair value of the Company's marketable securities.
5. Inventories
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Finished goods
560

 
514

Work-in-process
52

 
42

Raw materials and supplies
146

 
155

Total
758

 
711


12



6. Goodwill and Intangible Assets, Net
Goodwill
 
Advanced
Engineered
Materials
 
Consumer
Specialties
 
Industrial
Specialties
 
Acetyl
Intermediates
 
Total
 
(In $ millions)
As of December 31, 2012
 

 
 

 
 

 
 

 
 

Goodwill
297

 
249

 
42

 
189

 
777

Accumulated impairment losses

 

 

 

 

Net book value
297

 
249

 
42

 
189

 
777

Exchange rate changes
(4
)
 
(4
)
 
(1
)
 
(6
)
 
(15
)
As of March 31, 2013
 
 
 
 
 
 
 
 
 
Goodwill
293

 
245

 
41

 
183

 
762

Accumulated impairment losses

 

 

 

 

Net book value
293

 
245

 
41

 
183

 
762

Intangible Assets, Net
Finite-lived intangibles are as follows:
 
Licenses
 
Customer-
Related
Intangible
Assets
 
Developed
Technology
 
Covenants
Not to
Compete
and Other
 
Total
 
 
(In $ millions)
 
Gross Asset Value
 

 
 

 
 

 
 

 
 

 
As of December 31, 2012
32

 
525

 
30

 
32

 
619

 
Acquisitions

 

 

 
4

 
4

(1) 
Exchange rate changes

 
(11
)
 

 

 
(11
)
 
As of March 31, 2013
32

 
514

 
30

 
36

 
612

 
Accumulated Amortization
 
 
 
 
 
 
 
 
 
 
As of December 31, 2012
(16
)
 
(480
)
 
(17
)
 
(23
)
 
(536
)
 
Amortization
(1
)
 
(9
)
 
(1
)
 

 
(11
)
 
Exchange rate changes

 
10

 

 

 
10

 
As of March 31, 2013
(17
)
 
(479
)
 
(18
)
 
(23
)
 
(537
)
 
Net book value
15

 
35

 
12

 
13

 
75

 
______________________________
(1)  
Weighted average amortization period is 20 years.
Indefinite-lived intangibles are as follows:
 
Trademarks
and Trade Names
 
(In $ millions)
As of December 31, 2012
82

Acquisitions

Exchange rate changes
(2
)
As of March 31, 2013
80

The Company’s trademarks and trade names have an indefinite life. For the three months ended March 31, 2013, the Company did not renew or extend any intangible assets.

13



Estimated amortization expense for the succeeding five fiscal years is as follows:
 
(In $ millions)
2014
21

2015
10

2016
7

2017
6

2018
3

7. Current Other Liabilities
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Salaries and benefits
74

 
74

Environmental (Note 11)
21

 
21

Restructuring (Note 13)
25

 
30

Insurance
14

 
15

Asset retirement obligations
31

 
38

Derivatives (Note 15)
18

 
23

Current portion of benefit obligations
47

 
47

Interest
37

 
23

Sales and use tax/foreign withholding tax payable
18

 
17

Uncertain tax positions
60

 
65

Customer rebates
38

 
44

Other
76

 
78

Total
459

 
475

8. Noncurrent Other Liabilities
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Environmental (Note 11)
73

 
78

Insurance
61

 
58

Deferred revenue
34

 
36

Deferred proceeds(1)
882

 
909

Asset retirement obligations
25

 
26

Derivatives (Note 15)
4

 
8

Income taxes payable
3

 
2

Other
41

 
35

Total
1,123

 
1,152

______________________________
(1) 
Primarily relates to proceeds received from the Frankfurt, Germany Airport as part of a settlement for the Company to cease operations and sell its Kelsterbach, Germany manufacturing site, included in the Advanced Engineered Materials segment (Note 20). Such proceeds will be deferred until title transfers to the Frankfurt, Germany Airport.

14



9. Debt
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Short-Term Borrowings and Current Installments of Long-term Debt - Third Party and Affiliates
 
 
 
Current installments of long-term debt
23

 
60

Short-term borrowings, including amounts due to affiliates
89

 
108

Total
112

 
168

The Company's weighted average interest rate on short-term borrowings, including amounts due to affiliates, was 4.6% as of March 31, 2013 compared to 4.0% as of December 31, 2012.
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Long-Term Debt
 
 
 
Senior credit facilities - Term C loan due 2016
967

 
977

Senior unsecured notes due 2018, interest rate of 6.625%
600

 
600

Senior unsecured notes due 2021, interest rate of 5.875%
400

 
400

Senior unsecured notes due 2022, interest rate of 4.625%
500

 
500

Credit-linked revolving facility due 2014, interest rate of 1.7%
100

 
50

Pollution control and industrial revenue bonds, interest rates ranging from 5.7% to 6.7%, due at various dates through 2030
169

 
182

Obligations under capital leases due at various dates through 2054
246

 
244

Other bank obligations

 
37

Subtotal
2,982

 
2,990

Current installments of long-term debt
(23
)
 
(60
)
Total
2,959

 
2,930

Senior Notes
In November 2012, Celanese US completed an offering of $500 million in aggregate principal amount of 4.625% senior unsecured notes due 2022 (the "4.625% Notes") in a public offering registered under the Securities Act of 1933, as amended (the "Securities Act"). The 4.625% Notes are guaranteed on a senior unsecured basis by Celanese and each of the domestic subsidiaries of Celanese US that guarantee its obligations under its senior secured credit facilities (the "Subsidiary Guarantors").
The 4.625% Notes were issued under an indenture, dated May 6, 2011, as amended by a second supplemental indenture, dated November 13, 2012 (the "Second Supplemental Indenture") among Celanese US, Celanese, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as trustee. Celanese US will pay interest on the 4.625% Notes on March 15 and September 15 of each year which commenced on March 15, 2013. Prior to November 15, 2022, Celanese US may redeem some or all of the 4.625% Notes at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the Second Supplemental Indenture, plus accrued and unpaid interest, if any, to the redemption date. The 4.625% Notes are senior unsecured obligations of Celanese US and rank equally in right of payment with all other unsubordinated indebtedness of Celanese US.
In May 2011, Celanese US completed an offering of $400 million in aggregate principal amount of 5.875% senior unsecured notes due 2021 (the "5.875% Notes") in a public offering registered under the Securities Act. The 5.875% Notes are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors.

15



The 5.875% Notes were issued under an indenture and a first supplemental indenture, each dated May 6, 2011 (the "First Supplemental Indenture") among Celanese US, Celanese, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as trustee. Celanese US pays interest on the 5.875% Notes on June 15 and December 15 of each year which commenced on December 15, 2011. Prior to June 15, 2021, Celanese US may redeem some or all of the 5.875% Notes at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the First Supplemental Indenture, plus accrued and unpaid interest, if any, to the redemption date. The 5.875% Notes are senior unsecured obligations of Celanese US and rank equally in right of payment with all other unsubordinated indebtedness of Celanese US.
In September 2010, Celanese US completed the private placement of $600 million in aggregate principal amount of 6.625% senior unsecured notes due 2018 (the "6.625% Notes" and, together with the 4.625% Notes and the 5.875% Notes, collectively the "Senior Notes") under an indenture dated September 24, 2010 (the "Indenture") among Celanese US, Celanese, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as trustee. In April 2011, Celanese US registered the 6.625% Notes under the Securities Act. Celanese US pays interest on the 6.625% Notes on April 15 and October 15 of each year which commenced on April 15, 2011. The 6.625% Notes are redeemable, in whole or in part, at any time on or after October 15, 2014 at the redemption prices specified in the Indenture. Prior to October 15, 2014, Celanese US may redeem some or all of the 6.625% Notes at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the Indenture, plus accrued and unpaid interest, if any, to the redemption date. The 6.625% Notes are senior unsecured obligations of Celanese US and rank equally in right of payment with all other unsubordinated indebtedness of Celanese US. The 6.625% Notes are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors.
The Indenture and the First and Second Supplemental Indentures contain covenants, including, but not limited to, restrictions on the Company’s ability to incur indebtedness; grant liens on assets; merge, consolidate, or sell assets; pay dividends or make other restricted payments; engage in transactions with affiliates; or engage in other businesses.
Senior Credit Facilities
In September 2010, Celanese US, Celanese, and certain of the domestic subsidiaries of Celanese US entered into an amendment agreement with the lenders under Celanese US’s existing senior secured credit facilities in order to amend and restate the corresponding Credit Agreement, dated as of April 2, 2007 (as previously amended, the "Existing Credit Agreement", and as amended and restated by the amendment agreement, the "Amended Credit Agreement"). The Amended Credit Agreement consists of the Term C loan facility due 2016, the Term B loan facility due 2014, a $600 million revolving credit facility terminating in 2015 and a $228 million credit-linked revolving facility terminating in 2014.
In May 2011, Celanese US prepaid its outstanding Term B loan facility under the Amended Credit Agreement set to mature in 2014 with an aggregate principal amount of $516 million using proceeds from the 5.875% Notes and cash on hand.
In November 2012, Celanese US prepaid $400 million of its outstanding Term C loan facility under the Amended Credit Agreement set to mature in 2016 using proceeds from the 4.625% Notes.
The margin for borrowings under the revolving credit facility is currently 2.5% above LIBOR or EURIBOR, as applicable, subject to increase or reduction in certain circumstances based on changes in the Company’s corporate credit ratings. Borrowings under the credit-linked revolving facility and the Term C loan facility bear interest at a variable interest rate based on LIBOR (for US dollars) or EURIBOR (for Euros), plus a margin which varies based on the Company's net leverage ratio.
The estimated net leverage ratio and margin are as follows:
 
As of March 31, 2013
 
Estimated Total Net
Leverage Ratio
 
Estimated
Margin
Credit-linked revolving facility
1.56

 
1.50
%
Term C
1.56

 
2.75
%

16



The margin on each facility may increase or decrease 0.25% based on the following:
Credit-Linked Revolving Facility
 
Term C Loan Facility
Total Net Leverage Ratio
 
Margin over LIBOR
or EURIBOR
 
Total Net Leverage Ratio
 
Margin over LIBOR
or EURIBOR
< = 2.25
 
1.50%
 
< = 1.75
 
2.75%
> 2.25
 
1.75%
 
> 1.75 and < = 2.25
 
3.00%
 
 
 
 
> 2.25
 
3.25%
Term loan borrowings under the Amended Credit Agreement are subject to amortization at 1% of the initial principal amount per annum, payable quarterly. In addition, the Company pays quarterly commitment fees on the unused portions of the revolving credit facility and credit-linked revolving facility of 0.25% and 1.50% per annum, respectively.
The Amended Credit Agreement is guaranteed by Celanese and certain domestic subsidiaries of Celanese US and is secured by a lien on substantially all assets of Celanese US and such guarantors, subject to certain agreed exceptions (including for certain real property and certain shares of foreign subsidiaries), pursuant to the Guarantee and Collateral Agreement, dated as of April 2, 2007.
As a condition to borrowing funds or requesting letters of credit be issued under the revolving facility, the Company’s first lien senior secured leverage ratio (as calculated as of the last day of the most recent fiscal quarter for which financial statements have been delivered under the revolving facility) cannot exceed the threshold as specified below. Further, the Company’s first lien senior secured leverage ratio must be maintained at or below that threshold while any amounts are outstanding under the revolving credit facility.
The Company’s first lien senior secured leverage ratios and the borrowing capacity under the revolving credit facility are as follows:
 
As of March 31, 2013
 
First Lien Senior Secured Leverage Ratio
 
 
 
 
 
 
 
Estimate, if
Fully Drawn
 
Borrowing
Capacity
 
Maximum
 
Estimate
 
 
 
 
 
 
 
 
 
(In $ millions)
Revolving credit facility
3.90
 
0.91

 
1.41
 
600

The balances available for borrowing are as follows:
 
As of
March 31,
2013
 
(In $ millions)
Revolving Credit Facility
 

Borrowings outstanding

Letters of credit issued

Available for borrowing
600

Credit-Linked Revolving Facility
 
Borrowings outstanding
100

Letters of credit issued
78

Available for borrowing
50

The Amended Credit Agreement contains covenants including, but not limited to, restrictions on the Company’s ability to incur indebtedness; grant liens on assets; merge, consolidate, or sell assets; pay dividends or make other restricted payments; make investments; prepay or modify certain indebtedness; engage in transactions with affiliates; enter into sale-leaseback transactions or hedge transactions; or engage in other businesses.
The Amended Credit Agreement also maintains a number of events of default, including a cross default to other debt of Celanese, Celanese US, or their subsidiaries, including the Senior Notes, in an aggregate amount equal to more than $40 million and the occurrence of a change of control. Failure to comply with these covenants, or the occurrence of any other

17



event of default, could result in acceleration of the borrowings and other financial obligations under the Amended Credit Agreement.
The Company is in compliance with all of the covenants related to its debt agreements as of March 31, 2013.
In anticipation of a possible change in pension accounting policy, in January 2013, the Company entered into a non-material amendment to the Amended Credit Agreement with the effect that certain computations for covenant compliance purposes will be evaluated as if the change in pension accounting policy had not occurred. The amendment also modified the Amended Credit Agreement in other, non-material respects.
10. Benefit Obligations
As discussed in Note 1, effective January 1, 2013 the Company elected to change its policy for recognizing actuarial gains and losses and changes in the fair value of plan assets for its defined benefit pension plans and other postretirement benefit plans.  This accounting change has been applied retrospectively to all periods presented.
The components of net periodic benefit costs are as follows:
 
Pension Benefits
 
Postretirement
Benefits
 
Three Months Ended March 31,
 
2013
 
2012
 
2013
 
2012
 
 
 
As Adjusted (Note 1)
 
 
 
As Adjusted (Note 1)
 
(In $ millions)
Service cost
9

 
7

 
1

 

Interest cost
39

 
43

 
2

 
3

Expected return on plan assets
(56
)
 
(51
)
 

 

Recognized actuarial (gain) loss

 

 

 

Amortization of prior service cost (credit)

 
1

 

 

Curtailment (gain) loss

 

 

 

Total
(8
)
 

 
3

 
3

Commitments to fund benefit obligations during 2013 are as follows:
 
As of
March 31,
2013
 
Expected for 2013
 
(In $ millions)
Cash contributions to defined benefit pension plans
9

 
30

Benefit payments to nonqualified pension plans
6

 
22

Benefit payments to other postretirement benefit plans
4

 
24

The Company’s estimates of its US defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.
The Company participates in a multiemployer defined benefit plan in Germany covering certain employees. The Company’s contributions to the multiemployer defined benefit plan are based on specified percentages of employee contributions and totaled $2 million for the three months ended March 31, 2013.
11. Environmental
General
The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water and establish standards for the treatment, storage and disposal of solid and hazardous wastes. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.

18



The components of environmental remediation reserves are as follows:
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Demerger obligations (Note 17)
28

 
31

Divestiture obligations (Note 17)
21

 
21

Active sites
26

 
28

US Superfund sites
15

 
15

Other environmental remediation reserves
4

 
4

Total
94

 
99

Remediation
Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, orphan or US Superfund sites (as defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (Note 17). The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.
US Superfund Sites
In the US, the Company may be subject to substantial claims brought by US federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the US Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the Environmental Protection Agency, state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.
As events progress at each site for which it has been named a PRP, the Company accrues, as appropriate, a liability for site cleanup. Such liabilities include all costs that are probable and can be reasonably estimated. In establishing these liabilities, the Company considers its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party’s percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.
One such site is the Lower Passaic River Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the US Environmental Protection Agency ("EPA") to perform a Remedial Investigation/Feasibility Study ("RI/FS") of the contaminants in the lower 17-mile stretch known as the Lower Passaic River Study Area. The RI/FS is ongoing and may take several more years to complete. The Company is among a group of settling parties to a June 2012 Administrative Order on Consent with the EPA to perform a removal action on a small section of the river. The Company has also been named as a third-party defendant along with more than 200 other entities in an action initially brought by the New Jersey Department of Environmental Protection ("NJDEP") in the Supreme Court of New Jersey against Occidental Chemical Corporation and several other companies. This suit by the NJDEP seeks recovery of past and future clean-up costs, as well as unspecified economic damages, punitive damages, penalties and a variety of other forms of relief arising from alleged discharges into the Lower Passaic River.
In 2007, the EPA issued a draft study that evaluated alternatives for early remedial action of a portion of the Passaic River at an estimated cost of $900 million to $2.3 billion. Several parties commented on the draft study, and the EPA has announced its intention to issue a proposed plan in 2013. Although the Company's assessment that the contamination allegedly released by the Company is likely an insignificant aspect of the final remedy, because the RI/FS is still ongoing, and the EPA has not finalized

19



its study or the scope of requested cleanup the Company cannot reliably estimate its portion of the final remedial costs for this matter at this time. However, the Company currently believes that its portion of the costs would be less than approximately 1% to 2%. The Company is vigorously defending these and all related matters.
Environmental Proceedings
On January 7, 2013, following self-disclosures by the Company, the Company's Meredosia, Illinois site received a Notice of Violation/Finding of Violation from the US Environmental Protection Agency Region 5 ("EPA") alleging Clean Air Act violations. The Company is working with the EPA and with the state agency to reach a resolution of this matter. Based on currently available information and the Company's past experience, we do not believe that resolution of this matter will have a significant impact on the Company, even though the Company cannot conclude that a penalty will be less than $100,000. The Meredosia, Illinois site is included in the Industrial Specialties segment.
12. Stockholders’ Equity
Common Stock
The Company’s Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company’s Series A Common Stock, par value $0.0001 per share ("Common Stock") unless the Company’s Board of Directors, in its sole discretion, determines otherwise. The amount available to pay cash dividends is restricted by the Company’s Amended Credit Agreement and the Senior Notes.
Treasury Stock
The Company’s Board of Directors authorized the repurchase of Common Stock as follows:
 
Authorized Amount
 
(In $ millions)
February 2008
400

October 2008
100

April 2011
129

October 2012
264

As of March 31, 2013
893

The authorization gives management discretion in determining the timing and conditions under which shares may be repurchased. The repurchase program does not have an expiration date.
The share repurchase activity pursuant to this authorization is as follows:
 
Three Months Ended March 31,
 
Total From
February 2008 Through
March 31, 2013
 
 
2013
 
2012
 
 
Shares repurchased

 
444,901

 
13,142,527

(1) 
Average purchase price per share
$

 
$
46.34

 
$
38.14

 
Amount spent on repurchased shares (in millions)
$

 
$
20

 
$
501

 
______________________________
(1) 
Excludes 5,823 shares withheld from employee to cover statutory minimum withholding requirements for personal income taxes related to the vesting of restricted stock. Restricted stock is considered outstanding at the time of issuance and therefore, the shares withheld are treated as treasury shares.
The purchase of treasury stock reduces the number of shares outstanding and the repurchased shares may be used by the Company for compensation programs utilizing the Company’s stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of stockholders’ equity.

20



Other Comprehensive Income (Loss), Net
 
Three Months Ended March 31,
 
2013
 
2012
 
Gross
Amount
 
Income
Tax
(Provision)
Benefit
 
Net
Amount
 
Gross
Amount
 
 
Income
Tax
(Provision)
Benefit
 
Net
Amount
 
 
 
 
 
 
 
As Adjusted (Note 1)
 
(In $ millions)
Unrealized gain (loss) on marketable securities

 

 

 

 
 

 

Foreign currency translation
(31
)
 

 
(31
)
 
26

 
 

 
26

Gain (loss) on interest rate swaps
2

 
(1
)
 
1

 
2

 
 
(1
)
 
1

Pension and postretirement benefits

 

 

 
(1
)
(1) 
 
(3
)
 
(4
)
Total
(29
)
 
(1
)
 
(30
)
 
27

 
 
(4
)
 
23

______________________________
(1) 
Amount includes amortization of actuarial losses of $2 million related to the Company's equity method investments' pension plans.
Adjustments to Accumulated other comprehensive income (loss) are as follows:
 
Unrealized
Gain (Loss) on
Marketable
Securities
 
Foreign
Currency
Translation
 
Gain (Loss)
on Interest
Rate Swaps
 
Pension and
Postretire-
ment
Benefits
 
Accumulated
Other
Comprehensive
Income
(Loss), Net
 
(In $ millions)
As of December 31, 2012 - As Adjusted (Note 1)
(1
)
 
(23
)
 
(50
)
 
(15
)
 
(89
)
Other comprehensive income before reclassifications

 
(31
)
 

 

 
(31
)
Amounts reclassified from accumulated other comprehensive income

 

 
2

(1) 

(2) 
2

Income tax (provision) benefit

 

 
(1
)
 

 
(1
)
As of March 31, 2013
(1
)
 
(54
)
 
(49
)
 
(15
)
 
(119
)
______________________________
(1) 
This accumulated other comprehensive income component is related to interest rate swaps and is included in interest expense (Note 15).
(2) 
This accumulated other comprehensive income component is the amortization of prior service cost included in net periodic benefit cost (Note 10).
13. Other (Charges) Gains, Net
 
Three Months Ended
 
March 31,
 
2013
 
2012
 
(In $ millions)
Employee termination benefits
(2
)
 

Kelsterbach plant relocation (Note 20)
(2
)
 

Total
(4
)
 

During the three months ended March 31, 2013, the Company recorded $2 million of employee termination benefits related to a business optimization project which is included in the Industrial Specialties and Acetyl Intermediates segments.


21



The changes in the restructuring reserves by business segment are as follows:
 
Advanced
Engineered
Materials
 
Consumer
Specialties
 
Industrial
Specialties
 
Acetyl
Intermediates
 
Other
 
Total
 
(In $ millions)
Employee Termination Benefits
 

 
 

 
 

 
 

 
 

 
 

As of December 31, 2012
6

 
13

 

 
3

 
7

 
29

Additions

 

 
1

 
1

 

 
2

Cash payments
(1
)
 
(3
)
 

 

 
(2
)
 
(6
)
Other changes

 

 

 

 

 

Exchange rate changes

 

 

 

 

 

As of March 31, 2013
5

 
10

 
1

 
4

 
5

 
25

Plant/Office Closures
 

 
 

 
 

 
 

 
 

 
 

As of December 31, 2012

 

 

 
1

 

 
1

Additions

 

 

 

 

 

Cash payments

 

 

 

 

 

Other changes

 

 

 

 

 

Exchange rate changes

 

 

 
(1
)
 

 
(1
)
As of March 31, 2013

 

 

 

 

 

Total
5

 
10

 
1

 
4

 
5

 
25

14. Income Taxes
 
Three Months Ended
 
March 31,
 
2013
 
2012
 
 
 
As Adjusted (Note 1)
Effective income tax rate
35
%
 
(61
)%
The effective income tax rate for the three months ended March 31, 2012 would have been 19% excluding the recognition of foreign tax credit carryforwards, partially offset by the reassessment of certain permanently reinvested foreign earnings. As compared to the three months ended March 31, 2012, absent the effect of these events, the increase in the effective income tax rate for the three months ended March 31, 2013 was primarily due to losses in jurisdictions without income tax benefit, increased earnings in high income tax jurisdictions and reassessment of the recoverability of deferred tax assets in certain jurisdictions.
During the three months ended March 31, 2012, the Company amended certain prior year income tax returns to recognize the benefit of available foreign tax credit carryforwards. As a result, the Company recognized a tax benefit of $142 million. The available foreign tax credits are subject to a ten year carryforward period and expire beginning 2014 through 2021. The Company expects to fully utilize the credits within the prescribed carryforward period.
In February 2012, the Company amended its existing joint venture and other related agreements with its venture partner in Polyplastics Company, Ltd ("Polyplastics"). The amended agreements ("Agreements"), among other items, modified certain dividend rights, resulting in a cash dividend payment to the Company of $72 million during the three months ended March 31, 2012. In addition, as a result of the Agreements, Polyplastics is required to pay certain annual dividends to the venture partners. Consequently, Polyplastics' undistributed earnings will no longer be invested indefinitely. Accordingly, the Company recognized a deferred tax liability of $38 million that was recorded to Income tax provision (benefit) in the unaudited interim consolidated statement of operations during the three months ended March 31, 2012, related to the taxable outside basis difference of its investment in Polyplastics.
On January 2, 2013, the US enacted the American Taxpayer Relief Act of 2012 (the “2012 Tax Relief Act”). The 2012 Tax Relief Act extends many expired corporate income tax provisions through 2013, including the research and development credit, the look-through treatment of payments between related controlled foreign corporations, the active financing exception and

22



bonus depreciation, including retroactive application to January 1, 2012. These provisions did not have a significant impact on the Company.
Liabilities for uncertain tax positions and related interest and penalties are recorded in Uncertain tax positions and current Other liabilities in the unaudited consolidated balance sheets. For the three months ended March 31, 2013, the Company's uncertain tax positions increased $4 million due to interest and changes in uncertain tax positions in certain jurisdictions, and decreased $6 million due to exchange rate changes.
The Company's US tax returns for the years 2009 through 2011 are currently under audit by the US Internal Revenue Service and certain of the Company's subsidiaries are under audit in jurisdictions outside of the US. In addition, certain statutes of limitations are scheduled to expire in the near future. It is reasonably possible that a further change in the unrecognized tax benefits may occur within the next twelve months related to the settlement of one or more of these audits or the lapse of applicable statutes of limitations. Such amounts have been reflected in the current portion of uncertain tax positions (Note 7).
15. Derivative Financial Instruments
Interest Rate Risk Management
To reduce the interest rate risk inherent in the Company’s variable rate debt, the Company utilizes interest rate swap agreements to convert a portion of its variable rate borrowings into a fixed rate obligation. These interest rate swap agreements are designated as cash flow hedges and fix the LIBOR portion of the Company’s US-dollar denominated variable rate borrowings (Note 9). If an interest rate swap agreement is terminated prior to its maturity, the amount previously recorded in Accumulated other comprehensive income (loss), net is recognized into earnings over the period that the hedged transaction impacts earnings. If the hedging relationship is discontinued because it is probable that the forecasted transaction will not occur according to the original strategy, any related amounts previously recorded in Accumulated other comprehensive income (loss), net are recognized into earnings immediately.
US-dollar interest rate swap derivative arrangements are as follows:
As of March 31, 2013
Notional Value
 
Effective Date
 
Expiration Date
 
Fixed Rate (1)
(In $ millions)
 
 
 
 
 
 
1,100

 
January 2, 2012
 
January 2, 2014
 
1.71
%
500

 
January 2, 2014
 
January 2, 2016
 
1.02
%
______________________________
(1) 
Fixes the LIBOR portion of the Company's US-dollar denominated variable rate borrowings (Note 9).
As of December 31, 2012
Notional Value
 
Effective Date
 
Expiration Date
 
Fixed Rate (1)
(In $ millions)
 
 
 
 
 
 
1,100

 
January 2, 2012
 
January 2, 2014
 
1.71
%
500

 
January 2, 2014
 
January 2, 2016
 
1.02
%
______________________________
(1) 
Fixes the LIBOR portion of the Company's US-dollar denominated variable rate borrowings (Note 9).
Foreign Exchange Risk Management
Certain subsidiaries have assets and liabilities denominated in currencies other than their respective functional currencies, which creates foreign exchange risk. The Company also enters into foreign currency forwards and swaps to minimize its exposure to foreign currency fluctuations. Through these instruments, the Company mitigates its foreign currency exposure on transactions with third party entities as well as intercompany transactions. The foreign currency forwards and swaps are not designated as hedges under FASB ASC Topic 815, Derivatives and Hedging ("FASB ASC Topic 815"). Gains and losses on foreign currency forwards and swaps entered into to offset foreign exchange impacts on intercompany balances are classified as Other income (expense), net, in the unaudited interim consolidated statements of operations. Gains and losses on foreign currency forwards and swaps entered into to offset foreign exchange impacts on all other assets and liabilities are classified as Foreign exchange gain (loss), net, in the unaudited interim consolidated statements of operations.

23



Gross notional values of the foreign currency forwards and swaps are as follows:
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Total
802

 
902

Commodity Risk Management
The Company has exposure to the prices of commodities in its procurement of certain raw materials. The Company manages its exposure to commodity risk primarily through the use of long-term supply agreements, multi-year purchasing and sales agreements and forward purchase contracts. The Company regularly assesses its practice of using forward purchase contracts and other raw material hedging instruments in accordance with changes in economic conditions. Forward purchases and swap contracts for raw materials are principally settled through physical delivery of the commodity. For qualifying contracts, the Company has elected to apply the normal purchases and normal sales exception of FASB ASC Topic 815 based on the probability at the inception and throughout the term of the contract that the Company would not settle net and the transaction would result in the physical delivery of the commodity. As such, realized gains and losses on these contracts are included in the cost of the commodity upon the settlement of the contract.
In addition, the Company occasionally enters into financial derivatives to hedge a component of a raw material or energy source. Typically, these types of transactions do not qualify for hedge accounting. These instruments are marked to market at each reporting period and gains (losses) are included in Cost of sales in the unaudited interim consolidated statements of operations. During the three months ended March 31, 2013 and 2012, the Company did not have any open financial derivative contracts for commodities.
Information regarding changes in the fair value of the Company’s derivative arrangements is as follows:
 
Three Months Ended
 
Three Months Ended
 
 
March 31, 2013
 
March 31, 2012
 
 
Gain (Loss)
Recognized in
Other
Comprehensive
Income (Loss)
 
Gain (Loss)
Recognized in
Earnings (Loss)
 
Gain (Loss)
Recognized in
Other
Comprehensive
Income (Loss)
 
Gain (Loss)
Recognized in
Earnings (Loss)
 
 
(In $ millions)
Derivatives Designated as Cash Flow Hedges
 

 
 

 
 

 
 

 
Interest rate swaps

(1) 
(4
)
(2) 
(1
)
(3) 
(3
)
(2) 
Derivatives Not Designated as Hedges
 

 
 

 
 

 
 

 
Interest rate swaps

 
2

(4) 

 

(4) 
Foreign currency forwards and swaps

 
3

(5) 

 
(4
)
(5) 
Total

 
1

 
(1
)
 
(7
)
 
______________________________
(1) 
Amount excludes $1 million of tax expense recognized in Other comprehensive income (loss).
(2) 
Amount represents reclassification from Accumulated other comprehensive income (loss), net and is included in Interest expense in the unaudited interim consolidated statements of operations.
(3) 
Amount excludes $1 million of tax expense recognized in Other comprehensive income (loss).
(4) 
Included in Interest expense in the unaudited interim consolidated statements of operations.
(5) 
Included in Foreign exchange gain (loss), net for operating activity or Other income (expense), net for non-operating activity in the unaudited interim consolidated statements of operations.
See Note 16, Fair Value Measurements, for additional information regarding the fair value of the Company’s derivative arrangements.
Certain of the Company's foreign currency forwards and swaps and interest rate swap arrangements permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early

24



termination of the contract, similar to a master netting arrangement. The Company's interest rate swap agreements are subject to cross collateralization under the Guarantee and Collateral Agreement entered into in conjunction with the Term loan borrowings (Note 9).
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Derivative Assets
 
 
 
Gross amount recognized
5

 
2

Gross amount offset in the consolidated balance sheets

 

Net amount presented in the consolidated balance sheets
5

 
2

Gross amount not offset in the consolidated balance sheets
1

 
2

Net amount
4

 

 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Derivative Liabilities
 
 
 
Gross amount recognized
23

 
32

Gross amount offset in the consolidated balance sheets
1

 
1

Net amount presented in the consolidated balance sheets
22

 
31

Gross amount not offset in the consolidated balance sheets
1

 
2

Net amount
21

 
29

16. Fair Value Measurements
The Company follows the provisions of FASB ASC Topic 820 for financial assets and liabilities. FASB ASC Topic 820 establishes a three-tiered fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. Valuations for fund investments such as common/collective trusts and registered investment companies, which do not have readily determinable fair values, are typically estimated using a net asset value provided by a third party as a practical expedient.
The three levels of inputs are defined as follows:
Level 1 - unadjusted quoted prices for identical assets or liabilities in active markets accessible by the Company
Level 2 - inputs that are observable in the marketplace other than those inputs classified as Level 1
Level 3 - inputs that are unobservable in the marketplace and significant to the valuation
The Company’s financial assets and liabilities are measured at fair value on a recurring basis and include securities available for sale and derivative financial instruments. Securities available for sale include mutual funds. Derivative financial instruments include interest rate swaps and foreign currency forwards and swaps.
Marketable Securities. Where possible, the Company utilizes quoted prices in active markets to measure debt and equity securities; such items are classified as Level 1 in the hierarchy and include equity securities. When quoted market prices for identical assets are unavailable, varying valuation techniques are used. Common inputs in valuing these assets include, among others, benchmark yields, issuer spreads and recently reported trades. Such assets are classified as Level 2 in the hierarchy and typically include corporate bonds. Mutual funds are valued at the net asset value per share or unit multiplied by the number of shares or units held as of the measurement date.

25



Derivatives. Derivative financial instruments are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the hierarchy.
Assets and liabilities measured at fair value on a recurring basis are as follows:
 
 
 
Fair Value Measurement Using
 
Balance Sheet Classification
 
Quoted Prices in Active Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Total
 
 
 
(In $ millions)
Mutual funds
Marketable securities, at fair value
 
49

 

 
49

Derivatives Not Designated as Hedges
 
 
 
 
 
 
 
Foreign currency forwards and swaps
Current Other assets
 

 
5

 
5

Total assets as of March 31, 2013
 
49

 
5

 
54

Derivatives Designated as Cash Flow Hedges
 
 
 

 
 

 
 

Interest rate swaps
Current Other liabilities
 

 
(10
)
 
(10
)
Interest rate swaps
Noncurrent Other liabilities
 

 
(4
)
 
(4
)
Derivatives Not Designated as Hedges
 
 
 
 
 
 
 
Interest rate swaps
Current Other liabilities
 

 
(5
)
 
(5
)
Foreign currency forwards and swaps
Current Other liabilities
 

 
(3
)
 
(3
)
Total liabilities as of March 31, 2013
 

 
(22
)
 
(22
)
 
 
 
 
 
 
 
 
Mutual funds
Marketable securities, at fair value
 
53

 

 
53

Derivatives Not Designated as Hedges
 
 


 


 


Foreign currency forwards and swaps
Current Other assets
 

 
2

 
2

Total assets as of December 31, 2012
 
53

 
2

 
55

Derivatives Designated as Cash Flow Hedges
 
 
 

 
 

 
 

Interest rate swaps
Current Other liabilities
 

 
(10
)
 
(10
)
Interest rate swaps
Noncurrent Other liabilities
 

 
(7
)
 
(7
)
Derivatives Not Designated as Hedges
 
 
 
 
 
 
 
Interest rate swaps
Current Other liabilities
 

 
(5
)
 
(5
)
Interest rate swaps
Noncurrent Other liabilities
 

 
(1
)
 
(1
)
Foreign currency forwards and swaps
Current Other liabilities
 

 
(8
)
 
(8
)
Total liabilities as of December 31, 2012
 

 
(31
)
 
(31
)

26



Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
 
 
 
Fair Value Measurement Using
 
Carrying Amount
 
Significant Other
Observable Inputs
(Level 2)
 
Unobservable Inputs
(Level 3)
 
Total
 
 
 
(In $ millions)
As of March 31, 2013
 
 
 
 
 
 
 
Cost investments
155

 

 

 

Insurance contracts in nonqualified trusts
65

 
65

 

 
65

Long-term debt, including current installments of long-term debt
2,982

 
2,850

 
245

 
3,095

As of December 31, 2012
 
 
 
 
 
 
 
Cost investments
156

 

 

 

Insurance contracts in nonqualified trusts
66

 
66

 

 
66

Long-term debt, including current installments of long-term debt
2,990

 
2,886

 
244

 
3,130

In general, the cost investments included in the table above are not publicly traded and their fair values are not readily determinable; however, the Company believes the carrying values approximate or are less than the fair values. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the hierarchy. The fair value of obligations under capital leases is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 measurement.
As of March 31, 2013 and December 31, 2012, the fair values of cash and cash equivalents, receivables, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.
17. Commitments and Contingencies
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, commercial contracts, employment, antitrust, intellectual property, workers' compensation, chemical exposure, asbestos exposure, prior acquisitions and divestitures, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant. Due to the inherent subjectivity of assessments and unpredictability of outcomes of legal proceedings, the Company's litigation accruals and estimates of possible loss or range of possible loss ("Possible Loss") may not represent the ultimate loss to the Company from legal proceedings. For reasonably possible loss contingencies that may be material and when determinable, the Company estimates its Possible Loss, considering that the Company could incur no loss in certain matters. Thus, the Company's exposure and ultimate losses may be higher or lower, and possibly materially so, than the Company's litigation accruals and estimates of Possible Loss. For some matters, the Company is unable, at this time, to estimate its Possible Loss that is reasonably possible of occurring. Generally, the less progress that has been made in the proceedings or the broader the range of potential results, the more difficult for the Company to estimate the Possible Loss that it is reasonably possible the Company could incur. The Company may disclose certain information related to a plaintiff's claim against the Company alleged in the plaintiff's pleadings or otherwise publicly available. While information of this type may provide insight into the potential magnitude of a matter, it does not necessarily represent the Company's estimate of reasonably possible or probable loss. Some of the Company's exposure in legal matters may be offset by applicable insurance coverage. The Company does not consider the possible availability of insurance coverage in determining the amounts of any accruals or any estimates of Possible Loss.
Plumbing Actions
CNA Holdings LLC ("CNA Holdings"), a US subsidiary of the Company, which included the US business now in the Advanced Engineered Materials segment, along with Shell Oil Company ("Shell"), E.I. DuPont de Nemours and Company ("DuPont") and others, has been a defendant in a series of lawsuits, including a number of class actions, alleging that plastic

27



resins manufactured by these companies that were utilized by others in the production of plumbing systems for residential property were defective for this use and/or contributed to the failure of such plumbing. Based on, among other things, the findings of outside experts and the successful use of the Company's acetal copolymer in similar applications, CNA Holdings does not believe the Company's acetal copolymer was defective for this use or contributed to the failure of the plumbing. In addition, in many cases CNA Holdings' potential future exposure may be limited by, among other things, statutes of limitations and repose.
In November 1995, CNA Holdings, DuPont and Shell entered into national class action settlements in the Cox, et al. v. Hoechst Celanese Corporation, et al., No. 94-0047 (Chancery Ct., Obion County, Tennessee) matter. The time to file claims against the class has expired and the entity established by the court to administer the claims was dissolved in September 2010. In addition between 1995 and 2001, CNA Holdings was named as a defendant in various putative class actions. The majority of these actions have now been dismissed. The dismissal of the remaining US case (St. Croix, Ltd., et al. v. Shell Oil Company d/b/a Shell Chemical Company, Case No. XC-97-CR-467, Virgin Islands Superior Court) was appealed in 2011. Oral argument for the appeal took place on December 13, 2012 and a decision on the appeal is expected in 2013.
As of March 31, 2013, the class actions in Canada are subject to a pending class settlement that would result in a dismissal of those cases. The Company does not believe the Possible Loss associated with the remaining matters is material. During the three months ended March 31, 2013, the Company did not record any recoveries or reductions in legal reserves related to plumbing actions to Other (charges) gains, net (Note 13) in the unaudited interim consolidated statements of operations.
Polyester Staple Antitrust Litigation
CNA Holdings, the successor in interest to Hoechst Celanese Corporation ("HCC"), Celanese Americas Corporation and Celanese GmbH (collectively, the "Celanese Entities") and Hoechst, the former parent of HCC, were named as defendants in two actions (involving multiple individual participants) filed in September 2006 by US purchasers of polyester staple fibers manufactured and sold by HCC. The actions alleged that the defendants participated in a conspiracy to fix prices, rig bids and allocate customers of polyester staple sold in the US. These actions were consolidated in a proceeding by a Multi-District Litigation Panel in the US District Court for the Western District of North Carolina styled In re Polyester Staple Antitrust Litigation, MDL 1516. On June 12, 2008 the court dismissed these actions with prejudice against all Celanese Entities in consideration of a payment by the Company. This proceeding related to sales by the polyester staple fibers business which Hoechst sold to KoSa B.V., f/k/a Arteva B.V., a subsidiary of Koch Industries, Inc. ("KoSa") in 1998. In November 2003, KoSa sought recovery from the Company (Koch Industries, Inc. et al. v. Hoechst Aktiengesellschaft et al., No. 03-cv-8679 Southern District NY) alleging a variety of claims, including indemnification and breach of representations, arising out of the 1998 sale. During the fourth quarter of 2010, the parties settled the case pursuant to a confidential agreement and the case was dismissed with prejudice.
Prior to December 31, 2008, the Company had entered into tolling arrangements with four other alleged US purchasers of polyester staple fibers manufactured and sold by the Celanese Entities. These purchasers were not included in the settlement and one such company filed suit against the Company in December 2008 (Milliken & Company v. CNA Holdings, Inc., Celanese Americas Corporation and Hoechst AG (No. 8-SV-00578 W.D.N.C.)). On September 15, 2011, the case was dismissed with prejudice based on a stipulation and proposed order of voluntary dismissal. One of the alleged US purchasers made a demand to Celanese in February 2013 but has not filed a formal claim. The Company is evaluating its options, but does not believe a Possible Loss for this matter would be material.
Commercial Actions
In June 2012, Linde Gas Singapore Pte. Ltd. ("Linde Gas"), a raw materials supplier based in Singapore, initiated arbitration proceedings in New York against the Company's subsidiary, Celanese Singapore Pte. Ltd. ("Singapore Ltd."), alleging that Singapore Ltd. had breached a certain requirements contract for carbon monoxide by temporarily idling Singapore Ltd.'s acetic acid facility in Jurong Island, Singapore. The Company filed its answer on August 8, 2012. Linde is seeking damages in the amount of $38 million for the period ended December 31, 2012, in addition to other unspecified damages. The Company believes that Linde Gas' claims lack merit and that the Company has complied with the contract terms and is vigorously defending the matter. Based on the Company's evaluation of currently available information, the Company does not believe the Possible Loss is material. The arbitral panel has bifurcated the case into a liability and damages phase and set hearing dates for all liability issues in June 2013 and for all damages issues, if necessary, in December 2013.

28



Award Proceedings in Relation to Domination Agreement and Squeeze-Out
The Company's subsidiary, BCP Holdings GmbH ("BCP Holdings"), a German limited liability company, is a defendant in two special award proceedings initiated by minority stockholders of Celanese GmbH seeking the court's review of the amounts (i) of the fair cash compensation and of the guaranteed dividend offered in the purchaser offer under the 2004 Domination Agreement (the "Domination Agreement") and (ii) the fair cash compensation paid for the 2006 squeeze-out ("Squeeze-Out") of all remaining stockholders of Celanese GmbH.
Pursuant to a settlement agreement between BCP Holdings and certain former Celanese GmbH stockholders, if the court sets a higher value for the fair cash compensation or the guaranteed payment under the Domination Agreement or the Squeeze-Out compensation, former Celanese GmbH stockholders who ceased to be stockholders of Celanese GmbH due to the Squeeze-Out will be entitled to claim for their shares the higher of the compensation amounts determined by the court in these different proceedings related to the Domination Agreement and the Squeeze-Out. If the fair cash compensation determined by the court is higher than the Squeeze-Out compensation of €66.99, then 1,069,465 shares will be entitled to an adjustment. If the court determines the value of the fair cash compensation under the Domination Agreement to be lower than the original Squeeze-Out compensation, but determines a higher value for the Squeeze-Out compensation, 924,078 shares would be entitled to an adjustment. Payments already received by these stockholders as compensation for their shares will be offset so that persons who ceased to be stockholders of Celanese GmbH due to the Squeeze-Out are not entitled to more than the higher of the amount set in the two court proceedings.
In September 2011, the share valuation expert appointed by the court rendered an opinion. The expert opined that the fair cash compensation for these stockholders (145,387 shares) should be increased from €41.92 to €51.86. This non-binding opinion recommends a total increase in share value of €2 million for those claims under the Domination Agreement. The opinion has no effect on the Squeeze-Out proceeding because the share price recommended is lower than the price those stockholders already received in the Squeeze-Out. However, the opinion also advocates that the guaranteed dividend should be increased from €2.89 to €3.79, aggregating an increase in total guaranteed dividends of €1 million to the Squeeze-Out claimants. The Company and plaintiffs submitted written responses arguing for alternative valuations during the three months ended December 31, 2011. On March 27, 2013, the expert issued his supplementary opinion affirming his previous calculations. The Company anticipates the court setting a hearing date to take place in the second half of 2013. No hearing date has been set. Separately, no expert has yet been appointed in the Squeeze-Out proceedings.
For those claims brought under the Domination Agreement, based on the Company's evaluation of currently available information, including the non-binding expert opinions, and the fact that the court has not yet determined the applicable valuation method, which could increase or decrease the Company's potential exposure, the Company does not believe that the Possible Loss is material.
For those remaining claims brought by the Squeeze-Out claimants, based on the Company's evaluation of currently available information, including that damages sought are unspecified, unsupported or uncertain, the matter presents meaningful legal uncertainties (including novel issues of law and the applicable valuation method), there are significant facts in dispute and the court has not yet appointed an expert, the Company cannot estimate the Possible Loss, if any, at this time.
Guarantees
The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.
As indemnification obligations often depend on the occurrence of unpredictable future events, the future costs associated with them cannot be determined at this time.
The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims that have been brought to its attention. These known obligations include the following:
Demerger Obligations
In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (Note 11).

29



The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of March 31, 2013 are $62 million. Most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.
The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.
Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the Possible Loss for the remaining demerger obligations, if any, in excess of amounts accrued.
Divestiture Obligations
The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to any significant risk (Note 11).
The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, ranging from one year to thirty years. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $132 million as of March 31, 2013. Other agreements do not provide for any monetary or time limitations.
Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the Possible Loss for the remaining divestiture obligations, if any, in excess of amounts accrued.
Purchase Obligations
In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. The Company does not expect to incur any material losses under take-or-pay contractual arrangements. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of March 31, 2013, the Company had unconditional purchase obligations of $3.3 billion which extend through 2034.
The Company holds variable interests in entities that supply certain raw materials and services to the Company. The variable interests primarily relate to cost-plus contractual arrangements with the suppliers and recovery of capital expenditures for certain plant assets plus a rate of return on such assets. Liabilities for such supplier recoveries of capital expenditures have been recorded as capital lease obligations. The entities are not consolidated because the Company is not the primary beneficiary of the entities as it does not have the power to direct the activities of the entities that most significantly impact the entities' economic performance. The Company's maximum exposure to loss as a result of its involvement with these variable interest entities ("VIEs") as of March 31, 2013 relates primarily to early contract termination fees.

30



The Company's carrying value of assets and liabilities associated with its obligations to VIEs, as well as the maximum exposure to loss relating to these VIEs are as follows:
 
As of
March 31,
2013
 
As of
December 31,
2012
 
(In $ millions)
Property, plant and equipment, net
116
 
118
 
 
 
 
Trade payables
43
 
41
Current installments of long-term debt
7
 
7
Long-term debt
139
 
140
Total
189
 
188
 
 
 
 
Maximum exposure to loss
273
 
273
The difference between the total obligations to VIEs and the maximum exposure to loss, primarily represents take-or-pay obligations for services included within the unconditional obl